Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Chyme Reinfusion Restores the Regulatory Bile Salt-FGF19 Axis in Patients With Intestinal Failure

KVK. Koelfat, D. Picot, X. Chang, M. Desille-Dugast, HM. van Eijk, SMJ. van Kuijk, M. Lenicek, S. Layec, M. Carsin, L. Dussaulx, E. Seynhaeve, F. Trivin, L. Lacaze, R. Thibault, FG. Schaap, SWM. Olde Damink

. 2021 ; 74 (5) : 2670-2683. [pub] 20210826

Jazyk angličtina Země Spojené státy americké

Typ dokumentu klinické zkoušky, fáze II, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22011987

BACKGROUND AND AIMS: Automated chyme reinfusion (CR) in patients with intestinal failure (IF) and a temporary double enterostomy (TDE) restores intestinal function and protects against liver injury, but the mechanisms are incompletely understood. The aim was to investigate whether the beneficial effects of CR relate to functional recovery of enterohepatic signaling through the bile salt-FGF19 axis. APPROACH AND RESULTS: Blood samples were collected from 12 patients, 3 days before, at start, and 1, 3, 5, and 7 weeks after CR initiation. Plasma FGF19, total bile salts (TBS), 7-α-hydroxy-4-cholesten-3-one (C4; a marker of bile salt synthesis), citrulline (CIT), bile salt composition, liver tests, and nutritional risk indices were determined. Paired small bowel biopsies prior to CR and after 21 days were taken, and genes related to bile salt homeostasis and enterocyte function were assessed. CR induced an increase in plasma FGF19 and decreased C4 levels, indicating restored regulation of bile salt synthesis through endocrine FGF19 action. TBS remained unaltered during CR. Intestinal farnesoid X receptor was up-regulated after 21 days of CR. Secondary and deconjugated bile salt fractions were increased after CR, reflecting restored microbial metabolism of host bile salts. Furthermore, CIT and albumin levels gradually rose after CR, while abnormal serum liver tests normalized after CR, indicating restored intestinal function, improved nutritional status, and amelioration of liver injury. CR increased gene transcripts related to enterocyte number, carbohydrate handling, and bile salt homeostasis. Finally, the reciprocal FGF19/C4 response after 7 days predicted the plasma CIT time course. CONCLUSIONS: CR in patients with IF-TDE restored bile salt-FGF19 signaling and improved gut-liver function. Beneficial effects of CR are partly mediated by recovery of the bile salt-FGF19 axis and subsequent homeostatic regulation of bile salt synthesis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011987
003      
CZ-PrNML
005      
20220506130522.0
007      
ta
008      
220425s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/hep.32017 $2 doi
035    __
$a (PubMed)34133768
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Koelfat, Kiran V K $u Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands $u NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands $1 https://orcid.org/0000000252096775
245    10
$a Chyme Reinfusion Restores the Regulatory Bile Salt-FGF19 Axis in Patients With Intestinal Failure / $c KVK. Koelfat, D. Picot, X. Chang, M. Desille-Dugast, HM. van Eijk, SMJ. van Kuijk, M. Lenicek, S. Layec, M. Carsin, L. Dussaulx, E. Seynhaeve, F. Trivin, L. Lacaze, R. Thibault, FG. Schaap, SWM. Olde Damink
520    9_
$a BACKGROUND AND AIMS: Automated chyme reinfusion (CR) in patients with intestinal failure (IF) and a temporary double enterostomy (TDE) restores intestinal function and protects against liver injury, but the mechanisms are incompletely understood. The aim was to investigate whether the beneficial effects of CR relate to functional recovery of enterohepatic signaling through the bile salt-FGF19 axis. APPROACH AND RESULTS: Blood samples were collected from 12 patients, 3 days before, at start, and 1, 3, 5, and 7 weeks after CR initiation. Plasma FGF19, total bile salts (TBS), 7-α-hydroxy-4-cholesten-3-one (C4; a marker of bile salt synthesis), citrulline (CIT), bile salt composition, liver tests, and nutritional risk indices were determined. Paired small bowel biopsies prior to CR and after 21 days were taken, and genes related to bile salt homeostasis and enterocyte function were assessed. CR induced an increase in plasma FGF19 and decreased C4 levels, indicating restored regulation of bile salt synthesis through endocrine FGF19 action. TBS remained unaltered during CR. Intestinal farnesoid X receptor was up-regulated after 21 days of CR. Secondary and deconjugated bile salt fractions were increased after CR, reflecting restored microbial metabolism of host bile salts. Furthermore, CIT and albumin levels gradually rose after CR, while abnormal serum liver tests normalized after CR, indicating restored intestinal function, improved nutritional status, and amelioration of liver injury. CR increased gene transcripts related to enterocyte number, carbohydrate handling, and bile salt homeostasis. Finally, the reciprocal FGF19/C4 response after 7 days predicted the plasma CIT time course. CONCLUSIONS: CR in patients with IF-TDE restored bile salt-FGF19 signaling and improved gut-liver function. Beneficial effects of CR are partly mediated by recovery of the bile salt-FGF19 axis and subsequent homeostatic regulation of bile salt synthesis.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a anastomóza chirurgická $x škodlivé účinky $7 D000714
650    _2
$a žlučové kyseliny a soli $x krev $x metabolismus $7 D001647
650    _2
$a enterální výživa $x metody $7 D004750
650    _2
$a enterostomie $x škodlivé účinky $7 D004766
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibroblastové růstové faktory $x krev $x metabolismus $7 D005346
650    12
$a gastrointestinální obsah $7 D005766
650    _2
$a lidé $7 D006801
650    _2
$a selhání střeva $x krev $x etiologie $x metabolismus $x terapie $7 D000090124
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nutriční stav $7 D009752
650    _2
$a prospektivní studie $7 D011446
650    _2
$a výsledek terapie $7 D016896
655    _2
$a klinické zkoušky, fáze II $7 D017427
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Picot, Denis $u Department of Nutritional and Digestive Rehabilitation, Clinique Saint Yves, Rennes, France
700    1_
$a Chang, Xinwei $u Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands $u NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands
700    1_
$a Desille-Dugast, Mireille $u INSERM, INRAE, University of Rennes, Nutrition Metabolisms and Cancer, NuMeCan, Nutrition Unit, CRB Santé, CHU Rennes, Rennes, France
700    1_
$a van Eijk, Hans M $u Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands $u NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands
700    1_
$a van Kuijk, Sander M J $u Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center, Maastricht, the Netherlands
700    1_
$a Lenicek, Martin $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Layec, Sabrina $u Department of Nutritional and Digestive Rehabilitation, Clinique Saint Yves, Rennes, France
700    1_
$a Carsin, Marie $u Department of Nutritional and Digestive Rehabilitation, Clinique Saint Yves, Rennes, France
700    1_
$a Dussaulx, Laurence $u Department of Nutritional and Digestive Rehabilitation, Clinique Saint Yves, Rennes, France
700    1_
$a Seynhaeve, Eloi $u Department of Nutritional and Digestive Rehabilitation, Clinique Saint Yves, Rennes, France
700    1_
$a Trivin, Florence $u Department of Nutritional and Digestive Rehabilitation, Clinique Saint Yves, Rennes, France
700    1_
$a Lacaze, Laurence $u INSERM, INRAE, University of Rennes, Nutrition Metabolisms and Cancer, NuMeCan, Nutrition Unit, CRB Santé, CHU Rennes, Rennes, France
700    1_
$a Thibault, Ronan $u INSERM, INRAE, University of Rennes, Nutrition Metabolisms and Cancer, NuMeCan, Nutrition Unit, CRB Santé, CHU Rennes, Rennes, France
700    1_
$a Schaap, Frank G $u Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands $u NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands $u Department of General, Visceral and Transplantation Surgery, RWTH University Hospital Aachen, Aachen, Germany $1 https://orcid.org/000000021597572X
700    1_
$a Olde Damink, Steven W M $u Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands $u NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands $u Department of General, Visceral and Transplantation Surgery, RWTH University Hospital Aachen, Aachen, Germany
773    0_
$w MED00009806 $t Hepatology (Baltimore, Md.) $x 1527-3350 $g Roč. 74, č. 5 (2021), s. 2670-2683
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34133768 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130514 $b ABA008
999    __
$a ok $b bmc $g 1789534 $s 1163188
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 74 $c 5 $d 2670-2683 $e 20210826 $i 1527-3350 $m Hepatology $n Hepatology $x MED00009806
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Možnosti archivace